January 07, 2025 04:03 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad | Donald Trump repeats his US-Canada merger offer after Justin Trudeau's resignation | India's HMPV cases surge to 7 after two cases reported from Nagpur | H-1B visa renewal will get simpler in 2025, Indians to benefit most as home country travel won't be required | As India detects 3 HMPV cases, #lockdown trends; Centre says no need to panic | Justin Trudeau announces resignation as Canada's PM amid rising pressure by partymates | 8 jawans, driver killed as Maoists blow up security vehicle in Chhattisgarh's Bijapur | Atul Subhash suicide: Karnataka High Court refuses to quash FIR against wife Nikita Singhania | Delhi elections: Congress launches Pyari Didi scheme promising Rs. 2,500 per month to women residents
Pfizer
Wallpaper Cave

CEO says Pfizer vaccine is effective against all existing COVID-19 variants

| @indiablooms | Jun 11, 2021, at 02:23 pm

Washington/Sputnik: No COVID-19 variant has escaped the protection of Pfizer's vaccine, but the company continues to monitor and test it against emerging strains around the world, CEO Albert Bourla said on Thursday.

"We are also closely monitoring and addressing the emerging variants. We are testing our vaccines’ response to newly-arising variants and coordinating with public health authorities around the world on surveillance efforts... none of the existing variant strains has escaped the protection provided by our vaccine," Bourla said.

Bourla added, however, that Pfizer has developed a process to manufacture a new vaccine for the emerging strains within 100 days if need be.

In late May, the World Health Organization issued a new list of labels for so-called variants of concern, including the Delta variant, first identified in India, which now makes up more than 60% of new cases in the UK and more than 6% in the US.

The statement was made alongside President Joe Biden, who announced that Pfizer has agreed to partner with the US to donate half a billion vaccines to lower income countries around the world.

After purchasing the vaccines from Pfizer, the US plans on delivering 200 million doses by the end of 2021 and another 300 million in the first half of 2022 to 92 low and middle-income countries.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.